ProKidney Corp
PROK3.029USD
+0.209+7.41%
시장 운영 시간 （ET）시세는 15분 지연됩니다
392.38M시가총액
손실P/E TTM
자세한 내용은 ProKidney Corp 회사
ProKidney Corp. is a clinical-stage biotechnology company. The Company is focused on cell therapy platforms capable of treating multiple chronic kidney diseases (CKD) using a patient’s own cells isolated from the patient intended for treatment. The Company’s lead product candidate, Renal Autologous Cell Therapy (REACT), is designed to preserve kidney function in a CKD patient’s diseased kidneys. REACT is a product that includes autologous Selected Renal Cells (SRCs) prepared from a patient’s own (autologous) kidney cells. The REACT injection is an investigational therapy that is a mixture of kidney cells prepared from the participant’s own kidney tissue. Its patented technology includes multiple breakthroughs in the manufacturing and medical delivery of cellular therapy products. It is conducting a global Phase 3 development program and multiple Phase 2 clinical trials for REACT in subjects with moderate to severe diabetic kidney disease (DKD).
회사 정보
종목 코드 PROK
회사 이름ProKidney Corp
상장일Jun 30, 2021
CEODr. Bruce Culleton, M.D.
직원 수204
유형Ordinary Share
회계 연도 종료Jun 30
주소2000 Frontis Plaza Blvd.
도시WINSTON-SALEM
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호27103
전화13369997028
웹사이트https://prokidney.com/
종목 코드 PROK
상장일Jun 30, 2021
CEODr. Bruce Culleton, M.D.
회사 임원
이름
이름/직위
직위
주식 보유
변동
Dr. Bruce Culleton, M.D.
Dr. Bruce Culleton, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.54M
--
Mr. William F. (Bill) Doyle
Mr. William F. (Bill) Doyle
Independent Director
Independent Director
--
--
Dr. Brian J. G. Pereira, M.D.
Dr. Brian J. G. Pereira, M.D.
Independent Director
Independent Director
--
--
Dr. Darin J. Weber, Ph.D.
Dr. Darin J. Weber, Ph.D.
Chief Regulatory Officer, SVP - Global Regulatory, Quality Management & Commercial
Chief Regulatory Officer, SVP - Global Regulatory, Quality Management & Commercial
--
--
Mr. James Coulston, CPA
Mr. James Coulston, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Daniel Ferry
Mr. Daniel Ferry
IR Contact Officer
IR Contact Officer
--
--
Mr. Pablo Legorreta
Mr. Pablo Legorreta
Chairman of the Board
Chairman of the Board
--
--
Mr. Todd C. Girolamo, J.D.
Mr. Todd C. Girolamo, J.D.
Chief Legal Officer
Chief Legal Officer
--
--
Mr. Lucio Tozzi
Mr. Lucio Tozzi
Senior Vice President - Global Clinical Operations
Senior Vice President - Global Clinical Operations
--
--
Dr. Uma Sinha, Ph.D.
Dr. Uma Sinha, Ph.D.
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Bruce Culleton, M.D.
Dr. Bruce Culleton, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.54M
--
Mr. William F. (Bill) Doyle
Mr. William F. (Bill) Doyle
Independent Director
Independent Director
--
--
Dr. Brian J. G. Pereira, M.D.
Dr. Brian J. G. Pereira, M.D.
Independent Director
Independent Director
--
--
Dr. Darin J. Weber, Ph.D.
Dr. Darin J. Weber, Ph.D.
Chief Regulatory Officer, SVP - Global Regulatory, Quality Management & Commercial
Chief Regulatory Officer, SVP - Global Regulatory, Quality Management & Commercial
--
--
Mr. James Coulston, CPA
Mr. James Coulston, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Daniel Ferry
Mr. Daniel Ferry
IR Contact Officer
IR Contact Officer
--
--
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Thu, Jul 24
마지막 업데이트: Thu, Jul 24
주주
주주 유형
주주
주주
비율
Tolerantia LLC
17.46%
Suvretta Capital Management, LLC
9.53%
Control Empresarial de Capitales, S.A. de C.V.
8.28%
Morgan Stanley Investment Management Inc. (US)
7.75%
BlackRock Institutional Trust Company, N.A.
4.88%
Other
52.10%
주주
주주
비율
Tolerantia LLC
17.46%
Suvretta Capital Management, LLC
9.53%
Control Empresarial de Capitales, S.A. de C.V.
8.28%
Morgan Stanley Investment Management Inc. (US)
7.75%
BlackRock Institutional Trust Company, N.A.
4.88%
Other
52.10%
주주 유형
주주
비율
Corporation
25.74%
Investment Advisor
17.88%
Investment Advisor/Hedge Fund
12.42%
Hedge Fund
10.06%
Individual Investor
4.31%
Research Firm
0.78%
Endowment Fund
0.77%
Bank and Trust
0.09%
Pension Fund
0.03%
Other
27.93%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
186
93.75M
72.38%
-10.53M
2025Q1
188
90.99M
70.46%
-13.35M
2024Q4
184
92.39M
74.12%
+21.48M
2024Q3
176
90.75M
73.53%
+26.28M
2024Q2
216
81.85M
70.67%
+19.77M
2024Q1
231
37.73M
58.52%
-31.32M
2023Q4
239
39.92M
63.74%
-31.95M
2023Q3
236
64.28M
104.12%
-21.16M
2023Q2
223
59.02M
95.83%
-21.49M
2023Q1
183
53.54M
87.01%
-23.74M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Tolerantia LLC
22.62M
17.46%
--
--
Jun 03, 2025
Suvretta Capital Management, LLC
12.34M
9.53%
--
--
Mar 31, 2025
Control Empresarial de Capitales, S.A. de C.V.
10.72M
8.28%
+2.28M
+27.04%
Apr 22, 2025
Morgan Stanley Investment Management Inc. (US)
10.04M
7.75%
-3.51M
-25.90%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
6.32M
4.88%
+8.24K
+0.13%
Mar 31, 2025
The Vanguard Group, Inc.
5.21M
4.02%
-63.88K
-1.21%
Mar 31, 2025
BlackRock Mexico Operadora SA de CV SOFI
3.43M
2.65%
--
--
Mar 31, 2025
Palihapitiya (Chamath)
3.00M
2.32%
--
--
Nov 19, 2023
Operadora de Fondos GBM S.A.B. de C.V.
2.45M
1.89%
--
--
May 31, 2025
Geode Capital Management, L.L.C.
2.32M
1.79%
+90.34K
+4.05%
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Aug 2
마지막 업데이트: Sat, Aug 2
이름
비율
Schwab U.S. Broad Market ETF
0%
iShares Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
iShares MSCI USA Small-Cap Min Vol Factor ETF
0%
iShares Morningstar Small-Cap ETF
0%
Strive Small-Cap ETF
0%
Global X Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
Fidelity MSCI Health Care Index ETF
0%
더 보기
Schwab U.S. Broad Market ETF
비율0%
iShares Russell 2000 ETF
비율0%
Proshares Ultra Russell 2000
비율0%
iShares MSCI USA Small-Cap Min Vol Factor ETF
비율0%
iShares Morningstar Small-Cap ETF
비율0%
Strive Small-Cap ETF
비율0%
Global X Russell 2000 ETF
비율0%
iShares Russell 2000 Growth ETF
비율0%
Invesco Russell 2000 Dynamic Multifactor ETF
비율0%
Fidelity MSCI Health Care Index ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
